An article in the New York Times this past week reported that the United States was forced to import two chemotherapy drugs from abroad because U.S. companies could not produce enough of the required drugs in a sufficient amount of time. Shortages of both of these drugs “threatened the lives and care of thousands of [...]
Continue reading →